C12N 2760/00022
New viral proteins or individual genes, new structural or functional aspects of
Official title: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
C12N2760/00022 (New viral proteins or individual genes, new structural or functional aspects of) appears on 29 US grants and 27 published applications in this corpus.
Search patents in C12N- Granted patents
- 29
- Published applications
- 27
- Assignees
- 38
- Inventors
- 59
- Latest grant
- 2 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 1 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 6 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 1 | 0 |
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 1 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 1 | 1 |
| 2016 | 0 | 1 |
| 2017 | 2 | 3 |
| 2018 | 2 | 4 |
| 2019 | 1 | 3 |
| 2020 | 4 | 5 |
| 2021 | 2 | 1 |
| 2022 | 1 | 1 |
| 2023 | 3 | 2 |
| 2024 | 1 | 2 |
| 2025 | 1 | 1 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Recombinant human/bovine parainfluenza virus 3 (B/HPIV3) expressing a chimeric RSV/PIV3 F protein and uses thereof2 Jun 2026US 12,643,925 B2The U.S.A., as represented by the Secretary, Department of Health and Human Services
- Protein enriched microvesicles and methods of making and using the same3 Jun 2025US 12,319,934 B2Takara Bio USA, Inc.
- Recombinant human parainfluenza virus type 1 expressing a chimeric RSV/HPIV1 f protein and uses thereof25 Jun 2024US 12,018,051 B2The U.S.A., as represented by the Secretary, Department of Health and Human Services
- Protein enriched microvesicles and methods of making and using the same9 May 2023US 11,643,635 B2Takara Bio USA, Inc.
- Recombinant human/bovine parainfluenza virus 1 (HPIV1) expressing a chimeric RSV/HPIV1 F protein and uses thereof28 Feb 2023US 11,591,372 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Mrna vaccine for bandavirus dabieense and preparation method thereof6 Nov 2025US 2025/0339507 A1Nanjing Medical University
- Utilization of Micro-RNA for Downregulation of Cytotoxic Transgene Expression by Modified Vaccinia Virus Ankara (MVA)28 Nov 2024US 2024/0392257 A1Bavarian Nordic A/S
- Recombinant human/bovine parainfluenza virus 3 (b/hpiv3) expressing a chimeric rsv/piv3 f protein and uses thereof19 Sep 2024US 2024/0309053 A1The United States of America, as represented by the Secretary, Department of Health and Human Servic
- Recombinant human/bovine parainfluenza virus 1 (hpiv1) expressing a chimeric rsv/hpiv1 f protein and uses thereof14 Sep 2023US 2023/0287055 A1The United States of America, as represented by the Secretary, Department of Health and Human Ser.
- Protein Enriched Microvesicles and Methods of Making and Using the Same27 Jul 2023US 2023/0235278 A1Takara Bio USA, Inc.
Most cited
By later US patents
- Protein enriched microvesicles and methods of making and using the same19US 9,593,356 B2Takara Bio USA, Inc. · 2017
- Polypeptides p57 or p9.5 of Borna disease virus and their use for diagnosis and immunization14US 6,010,700 A2000
- Borna disease virus-specific protein and kits7US 5,654,401 AThe Johns Hopkins University · 1997
- Protein enriched microvesicles and methods of making and using the same6US 10,793,828 B2Takara Bio USA, Inc. · 2020
- Pharmaceutical compositions for prevention or treatment of neurodegenerative diseases4US 10,059,748 B2Centre National de la Recherche Scientifique (CNRS) · 2018